This large cohort study of women with breast cancer who underwent germline testing provided information about BRCA1 and BRCA2 in a population enriched for Hispanic women and reported the prevalence of P/LP variants when universal BRCA1 and BRCA2 testing is offered to women with breast cancer. The gene discussed is BRCA2; the disease is breast cancer.